FDA Inspection 738666 — Sucampo Pharma, LLC

Sucampo Pharma, LLC — FEI 3009036781

The FDA completed an inspection of Sucampo Pharma, LLC on Jul 29, 2011 in Kobe. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 29, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kobe (Japan)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.